Use of recombinant factor VIIa in the treatment of massive retroperitoneal bleeding due to severe necrotizing pancreatitis | Zendy

Branislav Stefanović | Zendy; Branislava Stefanović | Zendy; Srdjan Mijatović | Zendy; Dejan Radenković | Zendy; Nada Popović | Zendy; Ana Šijački | Zendy; Vesna Lačković | Zendy

Open Access

Use of recombinant factor VIIa in the treatment of massive retroperitoneal bleeding due to severe necrotizing pancreatitis

Author(s) -

Branislav Stefanović,

Branislava Stefanović,

Srdjan Mijatović,

Dejan Radenković,

Nada Popović,

Ana Šijački,

Vesna Lačković

Publication year - 2009

Publication title -

vojnosanitetski pregled

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.123

H-Index - 19

eISSN - 2406-0720

pISSN - 0042-8450

DOI - 10.2298/vsp0911928s

Subject(s) - medicine , surgery , recombinant factor viia , coagulopathy , tamponade , pancreatitis , hemostasis , disseminated intravascular coagulation , sepsis , discontinuation , bleed , anesthesia

Recently, a growing number of case reports and case series have suggested that the use of recombinant activated factor VII (rFVIIa) may be effective in treatment of patients with non-hemophilic acquired coagulopathy not responding to conventional treatment such as major surgery, major trauma, sepsis, necrotizing pancreatitis and bleeding due to cerebral arteriovenous malformations.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research